Akari Therapeutics, Plc | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (26)

Latest Posts

About This Stock More About This Stock
Akari Therapeutics' Nomacopan Is A Potential Blockbuster
Article By: Shareholders Unite
Thursday, November 9, 2023 9:50 AM EDT
Nomacopan, a complement dual wokring inhibitor, is a potential blockbuster with widespread use and already has an established safety profile.
In this article: AKTX
Read

Latest Tweets for $AKTX

No tweets yet!

PARTNER HEADLINES